首页> 外文期刊>Bali Medical Journal >The potential effect and delivery of piperine on breast cancer
【24h】

The potential effect and delivery of piperine on breast cancer

机译:哌啶对乳腺癌的潜在效果和递送

获取原文
获取外文期刊封面目录资料

摘要

Breast cancer is the most common malignancy in women worldwide. Breast cancer is associated with a high mortality rate and health-related economic burden. Breast cancer patients have a low 5-year life expectancy when diagnosed at advanced stages. Besides, the emergence of chemoresistance in breast cancer has led to an intense search for alternative anticancer agents. One of the potential anticancer compounds is Piperine. Several studies had found that Piperine has anticancer effects such as anti-proliferation, induces apoptosis, anti-migration or anti-metastasis, chemo-enhancer or chemosensitizer, cytotoxic agents, anti-angiogenesis, immune response modulators, and self-renewal inhibitor for cancer stem cells. Several delivery agents such as PLGA, PEG-PLGA and liposomes have been studied to improve Piperine's delivery and have shown good results. Therefore, the combination of Piperine and nanoparticles is a potential anticancer agent, especially in breast cancer.
机译:乳腺癌是全世界妇女最常见的恶性肿瘤。 乳腺癌与高死亡率和与健康有关的经济负担有关。 乳腺癌患者在诊断到高级阶段时患有5年的预期寿命低。 此外,乳腺癌中化学抑制的出现导致了对替代抗癌剂的激烈寻求。 其中一种潜在的抗癌化合物是哌啶。 一些研究发现哌啶患有抗癌等抗癌,诱导细胞凋亡,抗迁移或抗转移,化学增强剂或化学敏化剂,细胞毒性剂,抗血管生成,免疫应答调节剂和自我更新抑制剂 干细胞。 已经研究了几种递送剂,例如PLGA,PEG-PLGA和脂质体,以改善哌啶的递送,并显示出良好的结果。 因此,哌啶和纳米粒子的组合是潜在的抗癌剂,特别是在乳腺癌中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号